Role of Primary Afferents in Arthritis Induced Spinal Microglial Reactivity

Charlie H T Kwok1,2, Yuta Kohro1,2,3, Michael Mousseau1,2

  • 1Comparative Biology and Experimental Medicine, University of Calgary, Calgary, AB, Canada.

Insights

Peripheral joint injury activates spinal microglia via afferent nerve signals. Blocking these signals, like with ATP, prevents pain and microglial activation, suggesting a new therapeutic target for chronic pain.

Area of Science:

  • Neuroscience
  • Immunology
  • Pain Research

Background:

  • Microglia, the central nervous system's immune cells, are key in chronic pain development.
  • Peripheral joint injury can activate central nociceptive circuits through neuron-neuron and neuron-glia interactions.

Purpose of the Study:

  • To investigate how peripheral joint injury signals the central nervous system (CNS) to activate spinal microglia.
  • To explore the role of ATP signaling in mediating communication between sensory neurons and spinal microglia following joint injury.

Main Methods:

  • Monosodium iodoacetate (MIA)-induced knee joint injury in male rats.
  • Pharmacological silencing of C and A afferents using QX-314 and bupivacaine.
  • Measurement of Iba1 immunoreactivity, ATP levels in cerebrospinal fluid (CSF), and vesicular nucleotide transporter (VNUT) expression.
  • Replication of key findings in female rats.

Main Results:

  • MIA-induced joint injury increased peripheral afferent firing and spinal microglial activation (Iba1 immunoreactivity).
  • Silencing afferents prevented mechanical allodynia and microglial activation.
  • Elevated CSF ATP and spinal VNUT expression were observed post-MIA.
  • Blocking afferent signals inhibited CSF ATP release and alleviated pain.

Conclusions:

  • Early peripheral joint injury activates joint nociceptors, initiating a spinal microglial response.
  • ATP signaling, involving CSF ATP and spinal VNUT, may mediate communication between sensory neurons and microglia.
  • These findings highlight a potential therapeutic pathway for managing joint degeneration-related pain.